Cefiderocol's Effectiveness Against Eye Infections
Author Information
Author(s): Schilling Brennan, Hii Michael, Shanks Hazel Q., Romanowski Eric G., Mandell Jonathan B., Shanks Robert M. Q., Zegans Michael
Primary Institution: Dartmouth-Hitchcock Medical Center; The Charles T. Campbell Ophthalmic Microbiology Laboratory, University of Pittsburgh School of Medicine
Hypothesis
Cefiderocol may be more effective than traditional antibiotics for treating endophthalmitis caused by multi-drug-resistant bacteria.
Conclusion
Cefiderocol shows promise as an effective treatment for multi-drug-resistant Gram-negative bacteria in endophthalmitis, but further research is needed on its safety in the eye.
Supporting Evidence
- Cefiderocol had lower MIC values compared to ceftazidime for Pseudomonadales or Enterobacterales species.
- There was no antagonism observed between cefiderocol and vancomycin.
- 100% of tested Gram-negative organisms were susceptible to cefiderocol.
Takeaway
Cefiderocol is a new antibiotic that might work better than older ones for serious eye infections caused by tough bacteria.
Methodology
The study compared the minimum inhibitory concentrations (MIC) of cefiderocol, ceftazidime, and amikacin against endophthalmitis bacterial isolates using Epsilometer testing.
Potential Biases
There may be bias due to the oversampling of Gram-negative bacteria and the regional nature of the isolates.
Limitations
The study is limited by its regional focus on northeastern USA isolates and the lack of standardized susceptibility breakpoints for intravitreal therapy.
Participant Demographics
Bacterial strains isolated from patients with endophthalmitis.
Statistical Information
P-Value
p ≤ 0.0205
Statistical Significance
p ≤ 0.0205
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website